LDLR and atherosclerosis: Using a targeted knock-in mouse strain with a mutation in the kinase-domain of eEF2K (eef2k-KI18), we investigated whether eEF2K deficiency affects atherosclerosis development in vivo in low-density lipoprotein receptor-deficient (ldlr−/−) mice.